SlateStone Wealth’s P3 Health Partners PIII Stock Holding History

SlateStone Wealth’s Portfolio PIII Stock Details PIII Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-568	Closed	-$5K	–	299
2025 Q1	$5K	Hold	568	–	–	﹤0.01%	286
2024 Q4	$6K	Buy	568 +7	+1%	+$104	﹤0.01%	290
2024 Q3	$11K	Hold	561	–	–	﹤0.01%	292
2024 Q2	$13K	Hold	561	–	–	﹤0.01%	283
2024 Q1	$29K	Hold	561	–	–	﹤0.01%	279
2023 Q4	$40K	Buy	+561	New	+$38.7K	0.01%	236
2023 Q3	–	Sell	-261	Closed	-$39K	–	236
2023 Q2	$39K	Buy	+261	New	+$36.1K	0.01%	207

Other funds holding PIII

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Corient Private Wealth Miami, Florida $69.9B AUM 22.19% 1-Year Est. Return

TFA

Trinity Financial Advisors Columbus, Ohio $389M AUM 20.97% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

SlateStone Wealth's PIII Position: Q2 2025 in Review

SlateStone Wealth sold out of P3 Health Partners (PIII) in Q2 2025, closing a stake of 568 shares — an estimated $5K sold.

SlateStone Wealth first reported a position in PIII in Q2 2023 and held it in 7 quarters. The position peaked at $40K in Q4 2023. 16 funds tracked by Wall St. Rank hold PIII as of Q2 2025.

SlateStone Wealth reported no remaining P3 Health Partners position as of Q2 2025 after selling out during the quarter.
SlateStone Wealth sold 568 P3 Health Partners shares in Q2 2025, an estimated $5K.
SlateStone Wealth first reported a position in P3 Health Partners in Q2 2023 and held it in 7 quarters.
SlateStone Wealth's P3 Health Partners position peaked at $40K in Q4 2023.
16 funds tracked by Wall St. Rank held P3 Health Partners as of Q2 2025.

Based on SlateStone Wealth's 13F filing for Q2 2025, filed 12 Aug 2025.